The tangled web of dyslipidemia and cancer: Is there any association?
Cancer is a primary cause of mortality around the world and imposes a significant physiological, psychological, and financial burden on patients. Lipids regulate cell cycle progression and affect cell proliferation, migration, and apoptosis. Therefore, alterations in serum lipid levels might contrib...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Journal of Research in Medical Sciences |
| Subjects: | |
| Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2022;volume=27;issue=1;spage=93;epage=93;aulast=Neshat |
| _version_ | 1797954776482185216 |
|---|---|
| author | Sina Neshat Abbas Rezaei Armita Farid Rojin Sarallah Salar Javanshir Sarina Ahmadian Gelayol Chatrnour Padideh Daneii Kiyan Heshmat-Ghahdarijani |
| author_facet | Sina Neshat Abbas Rezaei Armita Farid Rojin Sarallah Salar Javanshir Sarina Ahmadian Gelayol Chatrnour Padideh Daneii Kiyan Heshmat-Ghahdarijani |
| author_sort | Sina Neshat |
| collection | DOAJ |
| description | Cancer is a primary cause of mortality around the world and imposes a significant physiological, psychological, and financial burden on patients. Lipids regulate cell cycle progression and affect cell proliferation, migration, and apoptosis. Therefore, alterations in serum lipid levels might contribute to carcinogenesis. In this article, we review the relationships between triglyceride (TG), total cholesterol, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels and different types of cancer. Then, we examine the association between cancer and familial hypercholesterolemia. Finally, we evaluate the impact of statins on different types of cancer. Increased total cholesterol has been reported to increase cellular proliferation and angiogenesis in tumors and inhibit apoptosis. Increased LDL-C has been reported to induce inflammation and increase susceptibility to oxidative damage. HDL-C has anti-oxidation, anti-inflammatory, and antiproliferative properties. Increased levels of serum TG can induce oxidative stress and a chronic inflammatory state and therefore contribute to the proliferation and progression of cancer cells. Statins decrease downstream products of cholesterol synthesis that are crucial in cell proliferation and growth. Thus, lipid components can have prognostic value in cancer and management of serum lipid levels through lifestyle changes and medical therapy can be beneficial in cancer prevention and treatment. |
| first_indexed | 2024-04-10T23:22:47Z |
| format | Article |
| id | doaj.art-1f371b7ae8e44f04a71b3d5e69e99205 |
| institution | Directory Open Access Journal |
| issn | 1735-1995 1735-7136 |
| language | English |
| last_indexed | 2024-04-10T23:22:47Z |
| publishDate | 2022-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Journal of Research in Medical Sciences |
| spelling | doaj.art-1f371b7ae8e44f04a71b3d5e69e992052023-01-12T13:26:35ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362022-01-01271939310.4103/jrms.jrms_267_22The tangled web of dyslipidemia and cancer: Is there any association?Sina NeshatAbbas RezaeiArmita FaridRojin SarallahSalar JavanshirSarina AhmadianGelayol ChatrnourPadideh DaneiiKiyan Heshmat-GhahdarijaniCancer is a primary cause of mortality around the world and imposes a significant physiological, psychological, and financial burden on patients. Lipids regulate cell cycle progression and affect cell proliferation, migration, and apoptosis. Therefore, alterations in serum lipid levels might contribute to carcinogenesis. In this article, we review the relationships between triglyceride (TG), total cholesterol, high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels and different types of cancer. Then, we examine the association between cancer and familial hypercholesterolemia. Finally, we evaluate the impact of statins on different types of cancer. Increased total cholesterol has been reported to increase cellular proliferation and angiogenesis in tumors and inhibit apoptosis. Increased LDL-C has been reported to induce inflammation and increase susceptibility to oxidative damage. HDL-C has anti-oxidation, anti-inflammatory, and antiproliferative properties. Increased levels of serum TG can induce oxidative stress and a chronic inflammatory state and therefore contribute to the proliferation and progression of cancer cells. Statins decrease downstream products of cholesterol synthesis that are crucial in cell proliferation and growth. Thus, lipid components can have prognostic value in cancer and management of serum lipid levels through lifestyle changes and medical therapy can be beneficial in cancer prevention and treatment.http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2022;volume=27;issue=1;spage=93;epage=93;aulast=Neshatcancercholesteroldyslipidemiahigh-density lipoprotein cholesterollow-density lipoprotein cholesterolstatins |
| spellingShingle | Sina Neshat Abbas Rezaei Armita Farid Rojin Sarallah Salar Javanshir Sarina Ahmadian Gelayol Chatrnour Padideh Daneii Kiyan Heshmat-Ghahdarijani The tangled web of dyslipidemia and cancer: Is there any association? Journal of Research in Medical Sciences cancer cholesterol dyslipidemia high-density lipoprotein cholesterol low-density lipoprotein cholesterol statins |
| title | The tangled web of dyslipidemia and cancer: Is there any association? |
| title_full | The tangled web of dyslipidemia and cancer: Is there any association? |
| title_fullStr | The tangled web of dyslipidemia and cancer: Is there any association? |
| title_full_unstemmed | The tangled web of dyslipidemia and cancer: Is there any association? |
| title_short | The tangled web of dyslipidemia and cancer: Is there any association? |
| title_sort | tangled web of dyslipidemia and cancer is there any association |
| topic | cancer cholesterol dyslipidemia high-density lipoprotein cholesterol low-density lipoprotein cholesterol statins |
| url | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2022;volume=27;issue=1;spage=93;epage=93;aulast=Neshat |
| work_keys_str_mv | AT sinaneshat thetangledwebofdyslipidemiaandcanceristhereanyassociation AT abbasrezaei thetangledwebofdyslipidemiaandcanceristhereanyassociation AT armitafarid thetangledwebofdyslipidemiaandcanceristhereanyassociation AT rojinsarallah thetangledwebofdyslipidemiaandcanceristhereanyassociation AT salarjavanshir thetangledwebofdyslipidemiaandcanceristhereanyassociation AT sarinaahmadian thetangledwebofdyslipidemiaandcanceristhereanyassociation AT gelayolchatrnour thetangledwebofdyslipidemiaandcanceristhereanyassociation AT padidehdaneii thetangledwebofdyslipidemiaandcanceristhereanyassociation AT kiyanheshmatghahdarijani thetangledwebofdyslipidemiaandcanceristhereanyassociation AT sinaneshat tangledwebofdyslipidemiaandcanceristhereanyassociation AT abbasrezaei tangledwebofdyslipidemiaandcanceristhereanyassociation AT armitafarid tangledwebofdyslipidemiaandcanceristhereanyassociation AT rojinsarallah tangledwebofdyslipidemiaandcanceristhereanyassociation AT salarjavanshir tangledwebofdyslipidemiaandcanceristhereanyassociation AT sarinaahmadian tangledwebofdyslipidemiaandcanceristhereanyassociation AT gelayolchatrnour tangledwebofdyslipidemiaandcanceristhereanyassociation AT padidehdaneii tangledwebofdyslipidemiaandcanceristhereanyassociation AT kiyanheshmatghahdarijani tangledwebofdyslipidemiaandcanceristhereanyassociation |